Berk Ozler's blog
There is a frustratingly weak and positive finding in the literature that examines the targeting performance of social funds projects, which, over time, took on many of the characteristics of community-driven development programs and became an important part of the social protection strategy in many countries by funding projects that provide public (and sometimes private) goods requested by communities: they are only moderately pro-poor.
Since I reviewed, back in April, the paper by Ashraf, Field, and Lee on the effect of providing vouchers for injectable contraceptives to women in reducing unwanted pregnancies in Lusaka, Zambia, I had been worrying about the use of these modern, convenient, and reliable technologies in those parts of the world in which HIV is highly prevalent.
Yesterday, in Part I of this post, we argued the extant empirical evidence suggests that the conditions cause a substantial amount of the desired behavior change intended by CCT programs. In other words: the “substitution effect” due to the condition may well be larger than the “income effect” of the transfers. For example, in the case of the Malawi experiment, the income effect was responsible for less than half of the total impact on school enrollment.
One of the questions discussed at the recent World Bank workshop on the "Second Generation of CCT Evaluations" (website, complete with at least some of the presentations, here) was the role of the first C in the performance of the CCT: how important is the condition in accounting for the outcomes of conditional cash transfer programs?
- Washington Post reports (citing a new study in the NEJM) that a program in the 1990s that offered women in public housing a chance to live in better neighborhoods has caused lower rates of diabetes and extreme obesity.
Tomorrow and on Tuesday (October 24-25), there is a workshop at the World Bank titled “CCTs: The Second Generation of Evaluations.” If you are at the World Bank or in the DC area, you may want to make your way to this event, as it promises to be a good one – focusing on research conducted on the topic in the past three years or so.
One of these men is receiving the bulk of the criticism in the development blogosphere. But, what about the people bankrolling him?
In this article in the NYT from a few weeks back, there is this quote from Dr. Stefano Bertozzi, director of H.I.V. and tuberculosis for the Bill and Melinda Gates Foundation: